X 
Directors Report
Home | Market Info | Company Profile | Directors Report
Inventurus Knowledge Solutions Ltd.
BSE CODE: 544309   |   NSE CODE: IKS   |   ISIN CODE : INE115Q01022   |   17-Apr-2025 Hrs IST
BSE NSE
Rs. 1417.10
4.5 ( 0.32% )
 
Prev Close ( Rs.)
1412.60
Open ( Rs.)
1390.05
 
High ( Rs.)
1423.45
Low ( Rs.)
1390.05
 
Volume
1822
Week Avg.Volume
5485
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 1416.40
2.9 ( 0.21% )
 
Prev Close ( Rs.)
1413.50
Open ( Rs.)
1419.00
 
High ( Rs.)
1424.50
Low ( Rs.)
1406.00
 
Volume
34010
Week Avg.Volume
131943
 
52 WK High-Low Range(Rs.)
1236.8
2189
March 2022

Description of state of companies affair

Your Company enables the enhanced delivery of exceptional health care for practicing physicians, medical groups and health systems. Supporting health care providers through every function of the patient visit, IKS is a go-to resource for organizations looking to effectively scale & improve quality through integrated technology and forward-thinking solutions. There has been no material change in the business of the Company during the financial year ended 31st March, 2022. During the year under review, your Company has strengthened its operations and made steady progress in terms of revenue as well as profitability. Through FY 2021-22, your Company continued to strengthen its foundation for scale.

Details regarding energy conservation

Conservation of energy: 1. The Company continues its efforts to improve methods of energy conservation and utilization. 2. Though the Company has not taken any special measures for utilizing alternative sources of energy, we have framed organization rules in a way to conserve energy as much as possible and are in constant efforts to conserve the same. 3. The Company has not made any Capital Investment on Energy Conservation Equipment.

Details regarding technology absorption

Technology absorption: 1. The Company has installed the best quality equipment so as to use the technology in the most economical way. 2. The Company has not imported any technology during the year under review. 3. The Company has not incurred any expenditure on research and development during the year under review.

Details regarding foreign exchange earnings and outgo

During the year under review, the foreign exchange earnings of the Company were Rs. 54,175.04 Lakhs whereas the foreign exchange outgo amounted to Rs. 3,283.06 Lakhs.

Disclosures in director’s responsibility statement

Pursuant to the requirements of Section 134(5) of the Act, the Board of Directors, to the best of its knowledge and ability, confirm that: 1. in the preparation of the annual accounts, the applicable accounting standards have been followed along with proper explanation relating to material departures, if any; 2. the Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at 31st March, 2022 and of the profit of the Company for that period; 3. the Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; 4. the Directors have prepared the annual accounts on a going concern basis; 5. The Directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively.